For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240118:nRSR0735Aa&default-theme=true
RNS Number : 0735A Accrol Group Holdings PLC 18 January 2024
18 January 2024
Accrol Group Holdings plc
("Accrol, the "Group" or the "Company")
Acquisition of Severn Delta Limited
Accrol (AIM: ACRL), the UK's leading independent tissue converter, is pleased
to announce that the Group has completed the acquisition of Severn Delta
Limited ("Severn Delta"), a £5m revenue wet wipe and tumble dryer sheet
manufacturer based in Somerset, for an EBITDA multiple of less than 3x before
synergies. The acquisition was funded from the Group's existing cash
reserves.
Acquisition rationale
The acquisition of Severn Delta demonstrates the Group's ambition to broaden
into other household products through strategic and complementary acquisitions
which strengthen and extend the existing product offering. Severn Delta brings
additional capacity and new capabilities to Accrol's growing wet wipe segment.
Severn Delta currently operates four production lines from its 33,000 sq.ft.
facility in Somerset, with three lines manufacturing biodegradable personal
care, household, and disinfectant wet wipes, and the other producing tumble
dryer sheets.
As a result of the successful acquisition and integration of John Dale in
April 2021 and the growth seen in the wet wipes business generally, it is
clear the Group can scale the business at pace, utilising Accrol's existing
relationships with UK retailers and grocers, as well as benefit from
cross-selling to the new key accounts Severn Delta brings.
Gareth Jenkins, Chief Executive Officer of Accrol, said:
"We are pleased to announce the acquisition of Severn Delta and welcome its
employees into the Group. Severn Delta enhances our market share in the wet
wipe segment and extends our product range, adding further personal care and
household wipes. The business currently operates four production lines which
we believe can be utilised further to support our customers with their growth
and generate a significant return on investment."
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Chris Welsh, Chief Financial Officer
Zeus (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King Tel: +44 (0) 203 829 5000
Shore Capital Stockbrokers (Joint Broker) Tel: +44 (0) 20 7408 4090
Malachy McEntyre/ Mark Percy / James Thomas / Isobel Jones
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com
(https://url.avanan.click/v2/___mailto:accrolpr@belvederepr.com___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6NjplZDQ5Ojk3ZmU0NGJlODE2ZDNiMDY2MTFjZmNmNjcyYWE3MDMwY2YzZWU3MGQxNjlkOGFkMzY3ZmE4NzA1ZGEyNWY4MmU6cDpU)
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet
tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's
leading discounters and grocery retailers across the UK. The Group now
operates from five manufacturing sites suppling the UK tissue wet wipes market
valued at over c£3.0bn at retail sales value.
For more information, please visit www.accrol.co.uk
(https://url.avanan.click/v2/___http:/www.accrol.co.uk/___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6Njo0YzVkOmEwY2Q0OTZhMWE2YTM0NjE1YjlkMjAyNGQ1ZmI2M2FhNjlmZTFkZjE5Mzk5OTdiNjA3Zjk3MzBkMTBmOTU4ZWM6cDpU)
.
Link for Accrol Today video: https://www.accrol.co.uk/our-business/
(https://url.avanan.click/v2/___https:/www.accrol.co.uk/our-business/___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6NjoxZGMxOmJjYmM3OTRhZjZiZGRhOTUxZmJiZDU4YmUwYmMzYzgxOTBlZDlkMTVkMzkxMDIzMWI0NDNiMTEwZGExMTg1ZDg6cDpU)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACQSFFFUWELSELF